Package Leaflet: Information for the User
rabeprazol cinfa 10 mg gastro-resistant tabletsEFG
Rabeprazole sodium
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
rabeprazol cinfa contains the active ingredient rabeprazole sodium. Rabeprazole belongs to a class of medicines known as “Proton Pump Inhibitors” (PPIs), which work by reducing the amount of acid produced by the stomach.
rabeprazol is used for the treatment of:
Do not take rabeprazol cinfa
Do not take rabeprazol if you are in any of the above situations. If you are not sure, consult your doctor or pharmacist before taking rabeprazol.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rabeprazol cinfa
If you are in doubt about any of the above, consult your doctor or pharmacist before taking rabeprazol.
During treatment with rabeprazol, kidney inflammation may occur. The signs and symptoms include: decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should report these signs to your doctor.
Children
Rabeprazol should not be given to children.
If you experience severe diarrhea (watery or bloody) with symptoms such as fever, abdominal pain, or sensitivity, stop taking rabeprazol and see your doctor immediately.
Taking a proton pump inhibitor like rabeprazol, especially for a period of more than a year, may slightly increase the risk of fracture in the hip, wrist, or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which may increase the risk of osteoporosis).
Taking rabeprazol cinfa with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
If you are in doubt about any of the above, consult your doctor or pharmacist before taking rabeprazol.
Taking rabeprazol cinfa with food and drinks
The tablets should be swallowed with a little water. If daily treatment is required, the tablets should be taken preferably before breakfast.
Pregnancy, breast-feeding, and fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Rabeprazol is unlikely to affect your ability to drive or use machines. However, if you feel drowsy, avoid driving or using machines.
Rabeprazol cinfa contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Follow exactly the instructions of administration of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking this medicine
Adults and elderly patients
For “gastroesophageal reflux disease” (GERD)
Treatment of moderate to severe symptoms (symptomatic GERD)
The recommended dose is one 10 mg rabeprazol tablet once a day for up to 4 weeks
Treatment of more severe symptoms (erosive or ulcerative GERD)
Long-term treatment of symptoms (maintenance GERD)
For stomach ulcers (peptic ulcers)
For duodenal ulcers
For ulcers caused by H. pylori infection and to prevent recurrence
For more information on the other medicines used to treat H. pylori, read the package leaflet of each of them.
Zollinger-Ellison syndrome where there is an excess of acid in the stomach
Patients with liver problems.Consult your doctor, who will take special care when starting and during treatment with rabeprazol.
If you take more rabeprazol cinfa than you should
If you take more rabeprazol than you should, talk to your doctor or go to a hospital immediately. Take the medicine with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take rabeprazol cinfa
If you stop taking rabeprazol cinfa
Relief of symptoms usually occurs before the ulcer is completely healed. It is important that you do not stop treatment until your doctor tells you to.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects are usually mild and improve without you stopping treatment.
Stop taking rabeprazol and see your doctor immediately if you notice any of the following side effects – you may need urgent medical treatment:
These side effects are rare (may affect up to 1 in 1,000 patients)
These side effects are very rare (may affect up to 1 in 10,000 patients)
Other possible side effects:
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Frequency not known (cannot be estimated from the available data)
If you take rabeprazol for more than three months, it is possible that your blood magnesium levels may decrease. Low magnesium levels can manifest as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate. If you experience any of these symptoms, please inform your doctor immediately. Low magnesium levels can also lead to a reduction in blood potassium or calcium levels. Your doctor may decide to perform periodic blood tests to monitor your magnesium levels.
Do not worry about the list of side effects. You may not experience any of them.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects that are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 25°C.
Store in the original package.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to a pharmacy for safe disposal. If you are in doubt, ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
Composition of Rabeprazole Cinfa
Core of the tablet: Mannitol, magnesium oxide (E-530), hydroxypropylcellulose (E-463), magnesium stearate (E-470b).
Intermediate coating: Ethylcellulose, magnesium oxide (E-530).
Enteric coating: Hypromellose phthalate, dibutyl sebacate, talc, titanium dioxide (E-171), red iron oxide (E-172).
Appearance of the Product and Packaging Content
Rabeprazole Cinfais presented in the form of pink, biconvex, film-coated tablets with a "1" on one face of the tablet. Each package contains 14, 28, or 120 (clinical package) tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Cinfa Laboratories, S.A.
Olaz-Chipi Road, 10. Areta Industrial Estate
31620 Huarte (Navarre) - Spain
Manufacturer
Cinfa Laboratories, S.A.
Olaz-Chipi Road, 10. Areta Industrial Estate
31620 Huarte (Navarre) - Spain
LICONSA, S.A.
Miralcampo Avenue, No. 7,
Miralcampo Industrial Estate
(Azuqueca de Henares (Guadalajara))
Spain
Date of the Last Revision of this Leaflet:September 2022
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
You can access detailed and updated information about this medicinal product by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address https://cima.aemps.es/cima/dochtml/p/72745/P_72745.html
QR code to: https://cima.aemps.es/cima/dochtml/p/72745/P_72745.html
The average price of RABEPRAZOL CINFA 10 mg GASTRO-RESISTANT TABLETS in October, 2025 is around 12.19 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.